BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20466184)

  • 1. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
    Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
    J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
    Magliocco MA; Gottlieb AB
    J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept therapy in patients with autoimmunity and hepatitis C.
    Khanna M; Shirodkar MA; Gottlieb AB
    J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
    Rokhsar C; Rabhan N; Cohen SR
    J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
    Collazo MH; González JR; Torres EA
    P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
    Zanni M; Missale G; Santilli D; Di Nuzzo S
    Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
    Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
    [No Abstract]   [Full Text] [Related]  

  • 9. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
    Girolomoni G; Abeni D
    Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
    Thayer S; Watson C; Song R; Globe DR; Harrison DJ
    J Med Econ; 2010; 13(2):228-35. PubMed ID: 20459298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.
    Prignano F; Ricceri F; Pescitelli L; Bonciani D; Lotti T
    Int J Dermatol; 2011 Aug; 50(8):999-1001. PubMed ID: 21781077
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept for the treatment of psoriasis and psoriatic arthritis.
    Gottlieb AB
    Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.
    D'Angelo S; Cutro MS; Lubrano E; Leccese P; Mennillo GA; Ferrara N; Olivieri I
    Ann Rheum Dis; 2010 May; 69(5):934-5. PubMed ID: 19666936
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.
    Nosotti L; Francesconi F; Izzi S; Berardesca E; Morrone A; Bonifati C
    Br J Dermatol; 2010 Jun; 162(6):1408-10. PubMed ID: 20184582
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 19. Etanercept: An overview.
    Goffe B; Cather JC
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S105-11. PubMed ID: 12894133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept for the treatment of psoriasis.
    Bissonnette R
    Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.